TREATMENTS WITH CORD BLOOD
Our hope is that no family ever needs a stem cell therapy to treat a life-threatening disease. Unfortunately, the reality is that many of us will experience one or more of these conditions in our, or our family’s lifetime. Research has projected that as many as 1 in 217 people could use a cord blood cell therapy in their lifetime1, and with the amazing progress researchers are making on conditions such as autism, Alzheimers’ disease, heart disease and diabetes, this number could substantially change in the foreseeable future. The graphic below shows all the potential diseases that are currently being researched or are in active clinical trials, using cord blood or cord tissue treatments.
BELOW IS A FULL LIST OF THE 80+ DISEASES THAT ARE CURRENTLY TREATABLE WITH CORD BLOOD.
CANCERS
- Acute lymphoblastic leukemia (ALL)
- Acute myeloid leukemia (AML)
- Burkitt’s lymphoma
- Chronic myeloid leukemia (CML)
- Juvenile myelomonocytic leukemia (JMML)
- Non-Hodgkin’s lymphoma Hodgkin’s lymphoma
- Lymphomatoid granulomatosis
- Myelodysplastic syndrome (MDS)
- Chronic myelomonocytic leukemia (CMML)
BONE MARROW FAILURE SYNDROMES
- Amegakaryocytic thrombocytopenia
- Autoimmune neutropenia (severe)
- Congenital dyserythropoietic anemia
- Cyclic neutropenia
- Diamond-Blackfan anemia
- Evan’s syndrome
- Fanconi anemia
- Glanzmann’s disease
- Juvenile dermatomyositis
- Kostmann’s syndrome
- Red cell aplasia
- Shwachman syndrome
- Severe aplastic anemia
- Congenital sideroblastic anemia
- Thrombocytopenia with absent radius (TAR syndrome)
- Dyskeratosis congenita
BLOOD DISORDERS
- Sickle-cell anemia (hemoglobin SS)
- HbSC disease
- Sickle βo Thalassemia
- α-thalassemia major (hydrops fetalis)
- β-thalassemia major (Cooley’s anemia)
- β-thalassemia intermedia
- E-βo thalassemia
- E-β+ thalassemia
METABOLIC DISORDERS
- Adrenoleukodystrophy Gaucher’s disease (infantile)
- Metachromatic leukodystrophy
- Krabbe disease (globoid cell leukodystrophy)
- Gunther disease
- Hermansky-Pudlak syndrome
- Hurler syndrome
- Hurler-Scheie syndrome
- Hunter syndrome
- Sanfilippo syndrome
- Maroteaux-Lamy syndrome
- Mucolipidosis Type II, III
- Alpha mannosidosis
- Niemann Pick Syndrome, type A and B
- Sandhoff Syndrome
- Tay-Sachs Disease
- Batten disease (inherited neuronal ceroid lipofuscinosis)
- Lesch-Nyhan disease
IMMUNODEFICIENCIES
- Ataxia telangiectasia
- Chronic granulomatous disease
- DiGeorge syndrome
- IKK gamma deficiency
- Immune dysregulation polyendocrineopathy
- X-linked Mucolipidosis, Type II
- Myelokathexis X-linked immunodeficiency
- Severe combined immunodeficiency
- Adenosine deaminase deficiency
- Wiskott-Aldrich syndrome
- X-linked agammaglobulinemia
- X-linked lymphoproliferative disease
- Omenn’s syndrome
- Reticular dysplasia
- Thymic dysplasia
- Leukocyte adhesion deficiency
OTHER
- Osteopetrosis
- Langerhans cell histiocytosis
- Hemophagocytic lymphohistiocytsis
1 Nietfeld JJ, Pasquini MC, Logan BR, et al. Lifetime probabilities of hematopoietic stem cell transplantation in the U.S. Biol Blood Marrow Transplant. 2008;14(3):316-322.
Clinical Trials
There are hundreds of clinical trials continually exploring new uses for cord blood stem cells and the mesenchymal stem cells found in amniotic fluid and cord tissue. Below is a short list highlighting some of the diseases and conditions most frequently asked about with stem cell clinical trials.
Autism
Cardiomyopathy
Cerebral Palsy
Compartment Syndrome (Battlefield Trauma)
Critical Limb Ischemia
Crohn’s Disease
Diabetes, Type 1 and Type 2
Hearing Loss (acquired sensorineural)
Hypoplastic Left Heart Syndrome (HLHS)
Hypoxic Ischemic Encephalopathy
Ischemic Heart Disease
Ischemic Stroke
Lupus
Multiple Sclerosis
Myocardial Infarction
Osteoarthritis
Rheumatoid Arthritis
Scleroderma
Support for Open Cardiac Surgery
Learn About Cord Blood Banking Services
Testimonials
“I banked my daughter’s cord blood and chose Core23 because my doctor recommended them.” – Gibson Family
About Core23
Core23 Biobank was founded by a group of experts in the field of cord blood banking and regenerative medicine.
For Families
Related stem cell products are very important when evaluating the genetic compatibility of a therapy.
Private Banking
There are three options for umbilical cord stem cell banking here you can explore and pick the plan that is right for you.